guangfeng ruan

Prof. Dr. guangfeng ruan


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2022 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
YZY. Zhang
Y. Zhang
DLD. Li
D. Li
ZZZhaohua Zhu
Zhaohua Zhu
SCS. Chen
S. Chen
MLM. Lu
M. Lu
CDChanghai Ding
Changhai Ding

18 August 2023 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
YZYan Zhang
Yan Zhang
JXJingyu Xie
Jingyu Xie
SWSimin Wen
Simin Wen
PCPeihua Cao
Peihua Cao
WXWende Xiao
Wende Xiao
GRguangfeng ruan
guangfeng ruan
Objectives This study aims to identify circulating proteins that are causally associated with osteoarthritis (OA)-related traits through Mendelian randomisation (MR)-based analytical framework. Methods Large-scale two-sample MR was employed to estimate the effects of thousands of plasma proteins on 12 OA-related traits. Additional analyses including Bayesian colocalisation, Steiger filtering analysis, assessment of protein-altering variants and mapping expression quantitative trait loci to protein quantitative trait loci were performed to investigate the reliability of the MR findings; protein–protein interaction, pathway enrichment analysis and evaluation of drug targets were conducted to deepen the understanding and identify potential therapeutic targets of OA. Results Dozens of circulating proteins were identified to have putatively causal effects on OA-related traits, and a majority of these proteins were either drug targets or considered druggable. Conclusions Through MR analysis, we have identified numerous plasma proteins associated with OA-related traits, shedding light on protein-mediated mechanisms and offering promising therapeutic targets for OA.

1 August 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
GRguangfeng ruan
guangfeng ruan
JXJ. Xu
J. Xu
KWK. Wang
K. Wang
JWJ. Wu
J. Wu
QZQ. Zhu
Q. Zhu
CDChanghai Ding
Changhai Ding


24 May 2022 in Science Signaling
Verified
Journal Article
Closed access
STSu’aN Tang
Su’aN Tang
YCYumei Cao
Yumei Cao
ZCZhaopeng Cai
Zhaopeng Cai
XNXiaoyu Nie
Xiaoyu Nie
JRJianzhao Ruan
Jianzhao Ruan
CDChanghai Ding
Changhai Ding
Inflammatory cytokine–induced activation of nuclear factor κB (NF-κB) signaling plays a critical role in the pathogenesis of osteoarthritis (OA). We identified PILA as a long noncoding RNA (lncRNA) that enhances NF-κB signaling and OA. The abundance of PILA was increased in damaged cartilage from patients with OA and in human articular chondrocytes stimulated with the proinflammatory cytokine tumor necrosis factor (TNF). Knockdown of PILA inhibited TNF-induced NF-κB signaling, extracellular matrix catabolism, and apoptosis in chondrocytes, whereas ectopic expression of PILA promoted NF-κB signaling and matrix degradation. PILA promoted PRMT1-mediated arginine methylation of DExH-box helicase 9 (DHX9), leading to an increase in the transcription of the gene encoding transforming growth factor β–activated kinase 1 (TAK1), an upstream activator of NF-κB signaling. Furthermore, intra-articular injection of an adenovirus vector encoding PILA triggered spontaneous cartilage loss and exacerbated posttraumatic OA in mice. This study provides insight into the regulation of NF-κB signaling in OA and identifies a potential therapeutic target for this disease.